Difference between revisions of "JMC Partners, APPC Register Entry for 1 June 2009 to 31 August 2009"
David Park (talk | contribs) (New page: {{Template:Lobbying_Portal_badge}} JMC Partners :APPC Register Entry for 1 June 2009 to 31 August 2009 ==Address(es)== === in UK=== :Contact: :61 Chandos Place :London :WC2N 4HG :Name:...) |
David Park (talk | contribs) m (→Fee-Paying clients) |
||
(One intermediate revision by the same user not shown) | |||
Line 27: | Line 27: | ||
*[[Galil Medical]] | *[[Galil Medical]] | ||
*[[Helperby Therapeutics]] | *[[Helperby Therapeutics]] | ||
− | *[[London Health Forum]] (www.london-health.org) | + | *[[London Health Forum]] (http://www.london-health.org) |
*[[Novo Nordisk Limited]] | *[[Novo Nordisk Limited]] | ||
*[[Sanofi-Aventis Limited]] | *[[Sanofi-Aventis Limited]] | ||
− | Specialised Healthcare Alliance (www.shca.info) | + | *[[Specialised Healthcare Alliance]] (http://www.shca.info) |
+ | |||
==Fee-Paying Clients== | ==Fee-Paying Clients== | ||
:(for whom only UK monitoring services provided this quarter) | :(for whom only UK monitoring services provided this quarter) |
Latest revision as of 12:20, 20 October 2009
This article is part of the Lobbying Portal, a sunlight project from Spinwatch. |
- APPC Register Entry for 1 June 2009 to 31 August 2009
Contents
Address(es)
in UK
- Contact:
- 61 Chandos Place
- London
- WC2N 4HG
- Name: John Murray
- Tel: 01435 872964
- Fax: On request
- Email: info@jmcinform.com
- Website: http://www.jmcinform.com
Offices outside UK
None
Staff
- (employed and sub-contracted) providing PA consultancy services this quarter
Fee-Paying clients
- (for whom UK PA consultancy services provided this quarter)
- AdvaMed
- ARMA
- Bard Limited
- Galil Medical
- Helperby Therapeutics
- London Health Forum (http://www.london-health.org)
- Novo Nordisk Limited
- Sanofi-Aventis Limited
- Specialised Healthcare Alliance (http://www.shca.info)
Fee-Paying Clients
- (for whom only UK monitoring services provided this quarter)
None
Pro-Bono Clients
- (for whom consultancy and/or monitoring services have been provided this quarter)
None